Replies to post #38961 on Relief Therapeutics Holding AG (RLFTF)

[mc67]

$RLFTF (related) Sevy Yh-0: We are now over 5 weeks out, first patient treated w/inhaled Zyesami.

Clinical trial NCT04360096.

NeuroRx Announces Dosing of First Patient with ZYESAMI™ in P2/3 Clinical Study for the Treatment of Moderate and Severe COVID-19 (AVICOVID-2)
3-19-21